new_0222_0337|CDAK|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0337|CDAK|1|Codiak BioSciences Inc Total Current Assets (Quarterly) (USD)|Codiak BioSciences Inc Cash and Short Term Investments (Quarterly) (USD)|Codiak BioSciences Inc Inventories (Quarterly) (USD)|Codiak BioSciences Inc Net PP&E (Quarterly) (USD)|Codiak BioSciences Inc Goodwill and Intangibles (Quarterly) (USD)|Codiak BioSciences Inc Total Liabilities (Quarterly) (USD)|Codiak BioSciences Inc Total Current Liabilities (Quarterly) (USD)|Codiak BioSciences Inc Total Long Term Liabilities (Quarterly) (USD)|Codiak BioSciences Inc Total Deposits (Quarterly) (USD)|Codiak BioSciences Inc Book Value (Quarterly) (USD)|Codiak BioSciences Inc Retained Earnings (Quarterly) (USD)|Codiak BioSciences Inc Treasury Stock (Quarterly) (USD)|Codiak BioSciences Inc EV to Revenues|Codiak BioSciences Inc EV to Earnings|Codiak BioSciences Inc EV to Free Cash Flow|Codiak BioSciences Inc EV to Assets (Quarterly)|Codiak BioSciences Inc PS Ratio|Codiak BioSciences Inc PE Ratio|Codiak BioSciences Inc Price to Book Value|Codiak BioSciences Inc PEG Ratio|Codiak BioSciences Inc Debt to Equity Ratio|Codiak BioSciences Inc Dividend Yield|Codiak BioSciences Inc Shareholder Yield (TTM)|Codiak BioSciences Inc Percent of Shares Outstanding Short|Codiak BioSciences Inc Total Receivables (Quarterly) (USD)|Codiak BioSciences Inc Total Payables (Quarterly) (USD)|Codiak BioSciences Inc Total Capital Stock (Quarterly) (USD)|Codiak BioSciences Inc Return on Invested Capital|Codiak BioSciences Inc Quality Ratio Score|Codiak BioSciences Inc Momentum Score|Codiak BioSciences Inc Beta (1Y)|Codiak BioSciences Inc Sustainable Growth Rate (TTM)|Codiak BioSciences Inc Institutional Investor Ownership Percentage|Codiak BioSciences Inc Average Diluted Shares Outstanding (Quarterly)|Codiak BioSciences Inc Total Employees (Annual)|Codiak BioSciences Inc EPS Diluted (Quarterly) (USD)|Codiak BioSciences Inc Shares Outstanding|Codiak BioSciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Codiak BioSciences Inc Ordinary Shares Number (Quarterly)|Codiak BioSciences Inc Payout Ratio|Codiak BioSciences Inc Quick Ratio (Quarterly)|Codiak BioSciences Inc Normalized Diluted EPS (Quarterly) (USD)|Codiak BioSciences Inc Stock Buybacks (Quarterly) (USD)|Codiak BioSciences Inc Effective Tax Rate (TTM)|Codiak BioSciences Inc Return on Equity|Codiak BioSciences Inc Net Income (TTM) (USD)|Codiak BioSciences Inc Revenue (TTM) (USD)|Codiak BioSciences Inc Dividend Per Share (Quarterly) (USD)|Codiak BioSciences Inc Revenue (Quarterly) (USD)|Codiak BioSciences Inc Gross Profit (Quarterly) (USD)|Codiak BioSciences Inc SG&A Expense (Quarterly) (USD)|Codiak BioSciences Inc Pre-Tax Income (Quarterly) (USD)|Codiak BioSciences Inc Net Income (Quarterly) (USD)|Codiak BioSciences Inc Net Interest Income (Quarterly) (USD)|Codiak BioSciences Inc Price (USD)|Codiak BioSciences Inc Total Return Price (USD)|Codiak BioSciences Inc Enterprise Value (USD)|Codiak BioSciences Inc 30-Day Average Daily Volume|Codiak BioSciences Inc 1 Year Price Returns (Daily)||
new_0222_0337|CDAK|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0337|CDAK|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0337|CDAK|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|1.44837758112|91|1.44912280702|91|1.44705882353|0|1.44755244755|0|91.2857142857|1.44837758112|91|15.2580645161|122|106.5|106.5|91.25|0|31|30.6666666667|0|0|91.375|122|91.375|27.9285714286|92|106.5|91.4|91.2857142857|91.375|91.3333333333|0|0|91.4|91.4|0|91.375|0|91.375|91.375|91.375|91.375|1.44705882353|1.44705882353|1.44837758112|1.45161290323|1.44827586207||
new_0222_0337|CDAK|6|6|6|0|6|0|6|6|6|0|6|6|0|339|3|285|3|340|0|286|0|7|339|3|31|3|6|6|4|0|2|3|0|0|8|1|8|14|1|6|5|7|8|6|0|0|5|5|0|8|0|8|8|8|8|340|340|339|310|87||
new_0222_0337|CDAK|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0337|CDAK|201909||||||||||||||||||||||||||||||||||13.1327||-1.8364||||||-1.5734|||||||0.151||4.835|-20.663|-20.663|0.341|||||||
new_0222_0337|CDAK|201912|94.118|83.381||17.626||94.011|19.755|74.256||-192.833|-192.878||||||||||0.4361||||5.91|2.381|214.784|||||||13.1327||-1.9107|||18.5942||4.5199|-1.6476|||||||0.15||4.253|-21.638|-21.638|0.058|||||||
new_0222_0337|CDAK|202003||||||||||||||||||||||||||||||||||13.1327||-1.9738||||||-1.7134|0||||||0.134||4.233|-22.502|-22.502|-0.072|||||||
new_0222_0337|CDAK|202006|52.568|50.947||53.509||123.585|18.691|104.894||-13.262|-212.036||||||||||-0.7319||||0|2.111|0.001|||||||18.5942|101|-1.0397|||18.5942|0|2.7258|-0.8558|0|||-80.716|0.622||0.187||4.358|-15.913|-15.913|-0.275|||||||
new_0222_0337|CDAK|202009|52.361|48.339||53.77||154.388|34.392|119.996||-269.07|-270.133||253.8954||||95.96||||-0.5637|0||2.2505|0|2.488|225.033|-3267.1388|||||22.1108|18.5942||-2.084|18.761|-1.167|18.5942|0|1.4055|-1.8981|1.167|||-95.346|1.425||0.954||5.342|-35.293|-35.293|-0.603|8.62|8.62|361.801|214732.7||13.01|
new_0222_0337|CDAK|202012|93.758|88.915||53.413||136.774|17.651|119.123||14.567|-288.09||186.2382|-5.9225|-6.4313|3.5872|191.4418||41.6585||1.7135|0|-13.0748|3.7349|0|2.018|0.002|-759.4134||||||18.7876|105|-1.14|18.7876|1.167|18.7876|0|5.0374|-1.14|-75.518|||-91.665|2.915||1.64||5.919|-17.957|-17.957|-0.703|32.3|32.3|542.8845|351456.2333||23.88|16.2
new_0222_0337|CDAK|202103|134.677|130.272||52.652||122.783|15.542|107.241||68.716|-298.398||14.1833|-2.8506|-3.1237|1.183|18.0119||4.8273||0.3652|0|-42.1025|2.8534||2.162|0.002|-287.4957||||||20.3334||-0.51|21.9969||21.9969|0|8.3819|-0.51|-62.204|||-79.471|15.972||13.191||6.588|-10.308|-10.308|-0.693|15.08|15.08|226.5363|137564.0333||19.8|22.62
new_0222_0337|CDAK|202106|119.322|113.681||51.782||123.41|20.921|102.489||51.864|-320.207||19.4463|-3.7985|-3.5415|1.8501|22.1784||7.9577||0.4865|0|-34.1826|5.3552||1.782|0.002|-227.4464||||||22.1176||-0.99|22.273||22.273|0|5.4338|-0.99|0.523|||-85.367|16.675||0.89||6.937|-21.809|-21.809|-0.695|18.53|18.53|324.2677|153738.0667||17.3|17.2
new_0222_0337|CDAK|202109|103.913|98.584||50.642||124.719|23.103|101.616||34.006|-341.909||17.2964|-4.0672|-3.2234|1.8392|20.2127||10.7381||0.7455|0|-38.4292|2.3068||1.998|0.002|-143.2209||8|3.9808|||22.3253||-0.97|22.3613||22.3613|0|4.2672|-0.97|0|||-71.776|16.878||1.157||7.186|-21.702|-21.702|-0.685|16.33|16.33|291.928|68881.9333|62.2748|14.41|12.75
new_0222_0337|CDAK|202112|||||||||||||10.4232||-1.9425||13.7887||7.3268|||0||2.4098||||||4|0.9265||||||||||||||||||||||||11.14|11.14|175.923|62572.6|-65.5108|6.62|4.55